Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Aromatase (CYP19A1) is a cytochrome P450 monooxygenase enzyme that catalyzes the conversion of androgens (androstenedione and testosterone) into estrogens (estrone and estradiol). It is essential for estrogen biosynthesis and plays a critical role in sexual development, bone growth, and glucose homeostasis. Aberrant aromatase activity is implicated in various diseases, including aromatase deficiency/excess syndromes and hormone-dependent cancers, making it a key therapeutic target for aromatase inhibitors.
Inhibition of estrogen synthesis by blocking the aromatase enzyme.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Aromatase enzyme (None).